心肌病动物模型:从分子机制解析到临床转化的核心桥梁
DOI:
作者:
作者单位:

(1.中国医学科学院医学实验动物研究所 国家动物模型技术创新中心 国家人类疾病动物模型资源库卫健委人类疾病比较医学重点实验室 北京市人类重大疾病实验动物模型工程技术研究中心,北京市 100021;2.中日友好医院(中日友好临床医学研究所) 中国医学科学院 北京协和医学院,北京市 100029)

作者简介:

王也,硕士研究生,研究方向为心血管疾病的病理机制,E-mail:y936583@163.com。

通讯作者:

基金项目:

国家重点研发计划项目(2022YFF0710600);国家自然科学基金项目(82270289)


Animal models of cardiomyopathy:bridging molecular mechanisms and clinical translation
Author:
Affiliation:

1.Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences & National Center of Technology Innovation for animal model & National Human Diseases Animal Model Resource Center & NHC Key Laboratory of Human Disease Comparative Medicine & Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Beijing 100021, China;2.China-Japan Friendship Hospital(Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100029,China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    心肌病是一组异质性心肌疾病,是心力衰竭和心源性猝死的主要病因,因此需要精确的动物模型来解析其复杂的病理生理学机制。本综述系统评估了扩张型心肌病(DCM)、肥厚型心肌病(HCM)、致心律失常型心肌病(ACM)及限制型心肌病(RCM)研究中所使用的关键动物模型,并指出其科学价值取决于具体的研究目标。以小鼠、斑马鱼为代表的小型动物模型,凭借繁殖周期短、饲养成本低的特点具备高通量优势,且依托成熟的遗传编辑技术,成为解析疾病初始分子机制的重要基础。相比之下,以猪、犬为代表的大型动物模型,因心脏生理特征、血流动力学表现及疾病进展过程与人类高度相似,构成了药物与器械疗效评估的关键临床前研究平台。本综述的分析框架与疾病的病因学紧密结合:对于主要由单基因突变驱动的HCM、ACM和RCM,综述重点聚焦于能精确复现人类致病突变的遗传工程模型;而针对病因异质的DCM,则系统梳理了涵盖遗传、药物/化学因素及血流动力学应激等因素的多样化模型。此外,本综述凸显了猫HCM模型和拳师犬ACM模型等自发性大型动物模型在模拟疾病自然病程中的独特价值,并讨论了各类模型的局限性与适用场景。

    Abstract:

    Cardiomyopathies, a heterogeneous group of myocardial disorders, represent a principal cause of heart failure and sudden cardiac death, necessitating precise animal models to dissect their complex pathophysiology. This review systematically evaluates the key animal models used in research on dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), arrhythmogenic cardiomyopathy (ACM), and restrictive cardiomyopathy (RCM), and points out that their scientific value depends on specific research objectives. Small animal models, exemplified by mice and zebrafish, serve as the cornerstone for elucidating initial molecular pathogenesis, owing to their short breeding cycles, low husbandry costs, high-throughput screening potertial and mature genetic eding systems. In contrast, large animal models, such as swine and canines, constitute a critical platform for preclinical evaluation of pharmacological and device-based therapies, given their high fidelity to human cardiac physiology, hemodynamics, and disease progression. The analytical framework of this review is tightly coupled to disease etiology:for HCM, ACM and RCM, which are predominantly driven by monogenic mutations, this review focuses on genetically engineered models that precisely recapitulate human pathogenic mutations; for the etiologically diverse DCM, this review systematically summarizes a full spectrum of models, including those induced by genetic defects, pharmaceutical/chemical factors, and hemodynamic stress. In addition, this review highlights the unique value of spontaneous large animal models, specifically the feline HCM model and the Boxer dog ACM model, in simulating the natural history of the disease, while also discussing the limitations and specific application scenarios of each model category.

    参考文献
    相似文献
    引证文献
引用本文

王也,李国庆,姜晓亮,杨志伟.心肌病动物模型:从分子机制解析到临床转化的核心桥梁[J].中国动脉硬化杂志,2026,34(4):277~286.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2025-09-28
  • 最后修改日期:2025-12-30
  • 录用日期:
  • 在线发布日期: 2026-05-06